About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

Heartseed Inc.(219A) Summary

219A
TSE Growth
Heartseed Inc.
1,900
JPY
-148
(-7.23%)
Apr 4, 3:30 pm JST
13.00
USD
Apr 4, 2:30 am EDT
Result
PTS
outside of trading hours
1,741
Apr 4, 9:09 pm JST
Summary Chart Historical News Financial Result
PER
PBR
6.84
Yield
ー%
Margin Trading Ratio
Stock Price
Apr 4, 2025
Opening Apr 4, 9:00 am
2,026 JPY 13.85 USD
Previous Close Apr 3
2,048 JPY 13.90 USD
High Apr 4, 9:00 am
2,055 JPY 14.05 USD
Low Apr 4, 12:43 pm
1,811 JPY 12.43 USD
Volume
1,106,000
Trading Value
2.12B JPY 0.01B USD
VWAP
1917.9 JPY 13.13 USD
Minimum Trading Value
190,000 JPY 1,300 USD
Market Cap
0.04T JPY 0.29B USD
Number of Trades
4,508
Liquidity & Number of Trades
As of Apr 4, 2025
Liquidity
High
1-Year Average
3,838
1-Year High Oct 4, 2024
28,900
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 28, 2025 0 2,138,900
Mar 21, 2025 1,800 2,027,100 1126.17
Mar 14, 2025 0 1,944,100
Mar 7, 2025 0 2,048,600
Feb 28, 2025 0 2,118,300
Company Profile
Heartseed Inc. engages in the research and development of regenerative medicine products using iPS cells for cardiac regeneration.
Sector
Pharmaceuticals
Heartseed Inc. is a regenerative medicine venture originating from Keio University. The company is advancing the development of "cardiac regenerative medicine," a treatment method that involves transplanting micro-tissues (cardiac spheroids) derived from iPS cell-based cardiomyocytes into the heart, aiming to establish safety and efficacy. Heartseed possesses proprietary technologies, including techniques for producing high-purity cardiomyocytes and transplantation devices. With a vision for global expansion of cardiac regenerative medicine using allogeneic iPS cell-derived cardiac spheroids, the company entered into an exclusive worldwide technology partnership and licensing agreement with Novo Nordisk, a global pharmaceutical giant headquartered in Denmark, in May 2021.